1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

AliveX Biotech

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2019

Location

Shanghai China

Primary Industry

Healthcare

About

Established in 2019 and based in Shanghai, China, AliveX Biotech is a biotechnology compaany. Jian Wen, the chairman of the board and the co-founder of the company, was dean of PLA Army General Hospital. The company focuses on the research and development of diagnosis and treatment solutions in the field of tumors and autoimmune diseases based on artificial intelligence. The company provides products and businesses including early screening of tumors and autoimmune diseases, treatment monitoring.
Current Investors
5Y Capital, Cherubic Ventures, K2VC

Request a demo to show more

Primary Industry
Healthcare
Sub Industries
Molecular Science, Genetics & Gene Therapy, Diagnostic, Medical & Imaging Laboratories, Healthcare IT, Medical Software
Website
www.alivexbiotech.com
Verticals
Artificial Intelligence, HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.